Ling He

Ling Ling is an accomplished professional in clinical bioanalysis with extensive experience spanning over two decades. Currently serving as Senior Director at Daiichi Sankyo Pharma Development since October 2006, Ling Ling oversees the clinical bioanalysis function that supports global clinical development programs from phases 1 to 3, specializing in regulated bioanalysis for chemical and biologic therapeutics. Prior experience includes leadership as Associate Director at QPS, where Ling Ling headed the Discovery Bioanalysis group focusing on antisense drug metabolism, and as Associate Principal Scientist at Schering-Plough Research Institute, where responsibilities included structural elucidation and the implementation of laboratory information management systems. Ling Ling holds a Ph.D. in Analytical Chemistry from the University of Michigan and a Bachelor's degree in Chemistry from Peking University.